european heart journal case reports

[1] intravenous thrombolysis after reversal of dabigatran by idarucizumab: a case report

[2] use of idarucizumab for dabigatran reversal: emergency department experience in two cases with subdural haematoma

[3] Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program.

[4] Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: a case report of first use in Latin America.

[5] intravenous thrombolysis after reversal of dabigatran by idarucizumab: a case report

[6] use of idarucizumab for dabigatran reversal: emergency department experience in two cases with subdural haematoma

[7] reversal of dabigatran using idarucizumab in a septic patient with impaired kidney function in real-life practice